Dr. Giulia Veronesi  is chief of the Robotic Thoracic Surgery Unit among the Division of Thoracic and General Surgery in Humanitas Research Hospital.

She is member of the committee on robotic cardio-thoracic surgery of the European Association for Cardio-Thoracic Surgery (EACTS) and faculty member of European Society of Thoracic Surgery (ESTS). She is also a founding member of the Clinical Robotic Surgical Association (CRSA). She is active member of other international societies such as the International  Association on Study of Lung Cancer and the European Society of Medical Oncology .

Since 2004 she  has led one of the largest European lung cancer screening programs (the COSMOS 1 and 2 studies) using low dose Computer Thomography   and molecular markers in high risk individuals.

Since 2006 she developed a pioneer program the robotic surgery program for thoracic disease and performed more than 250 robotic surgical procedures as first surgeon. Recently she become proctor of robotic surgery and trained thoracic surgeons in Geneve Huniversity Hospital and in different  italian centers.
She is Principal investigator of different NCI-supported trials focused mainly on lung cancer chemoprevention including the ongoing randomised double-blind phase II cancer prevention trial comparing daily aspirin with placebo in persons with subsolid nodules on LDCT.
She designed and coordinated an ongoing Italian multicentric randomised trial on limited resection versus standard lobectomy for stage Ia non small cell lung cancer.
She has been invited speaker at more than 60 national and international conferences as expert in the field of lung cancer prevention, lung cancer early detection and robotic minimally invasive thoracic surgery.
She is author and coauthor of more than 150 papers on international peer reviewed journals and authors of 8 book chapters. HI 22, IF 256.



  • http://www.ncbi.nlm.nih.gov/pubmed/?term=veronesi+giulia
  • http://www.annsurgoncol.org/journals/search_results.html?s=%22giulia%20veronesi%22&o=false